Author

Bongiovanni L

MD - Cited by 431

Biography

Dr. Bongiovanni L works in Department of Internal Medicine and Cardioangiology Ward is a well known researcher in field of Internal Medicine and Cardioangiology Ward. One of their renowned works are Microscopic Colitis as a Diagnosis to Consider by Clinicians and Pathologists Together: A Case Series and Review of Literature
Title
Cited by
Year
Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironment
L Danelli, B Frossi, G Gri, F Mion, C Guarnotta, L Bongiovanni, C Tripodo, ...Cancer immunology research 3 (1), 85-95, 2015201
63
2015
Trabectedin overrides osteosarcoma differentiative block and reprograms the tumor immune environment enabling effective combination with immune checkpoint inhibitors
C Ratti, L Botti, V Cancila, S Galvan, I Torselli, C Garofalo, MC Manara, ...Clinical Cancer Research 23 (17), 5149-5161, 2017201
53
2017
Cross-talk between myeloid-derived suppressor cells and mast cells mediates tumor-specific immunosuppression in prostate cancer
E Jachetti, V Cancila, A Rigoni, L Bongiovanni, B Cappetti, B Belmonte, ...Cancer immunology research 6 (5), 552-565, 2018201
48
2018
Mast cells infiltrating inflamed or transformed gut alternatively sustain mucosal healing or tumor growth
A Rigoni, L Bongiovanni, A Burocchi, S Sangaletti, L Danelli, C Guarnotta, ...Cancer research 75 (18), 3760-3770, 2015201
36
2015
The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation
M Frenquelli, N Caridi, E Antonini, F Storti, V Viganò, M Gaviraghi, ...Leukemia 34 (1), 257-270, 2020202
35
2020
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression
D Farinello, M Wozińska, E Lenti, L Genovese, S Bianchessi, E Migliori, ...Nature communications 9 (1), 1787, 2018201
25
2018
Three-dimensional co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents
F Barbaglio, D Belloni, L Scarfò, FV Sbrana, M Ponzoni, L Bongiovanni, ...Haematologica 106 (9), 2334, 212
20
2021
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies
OA Botrugno, S Bianchessi, D Zambroni, M Frenquelli, D Belloni, ...Haematologica 105 (10), 2448, 2020202
14
2020
Imatinib spares cKit-expressing prostate neuroendocrine tumors, whereas kills seminal vesicle epithelial–stromal tumors by targeting PDGFR-β
E Jachetti, A Rigoni, L Bongiovanni, I Arioli, L Botti, M Parenza, V Cancila, ...Molecular cancer therapeutics 16 (2), 365-375, 2017201
14
2017
Transcriptional profiles and stromal changes reveal bone marrow adaptation to early breast cancer in association with deregulated circulating microRNAs
C Chiodoni, V Cancila, TA Renzi, M Perrone, AM Tomirotti, S Sangaletti, ...Cancer Research 80 (3), 484-498, 2020202
12
2020
A ceRNA approach may unveil unexpected contributors to deletion syndromes, the model of 5q-syndrome
W Arancio, SI Genovese, L Bongiovanni, C TripodoOncoscience 2 (10), 872, 2015201
11
2015
Repurposing of the antiepileptic drug levetiracetam to restrain neuroendocrine prostate cancer and inhibit mast cell support to adenocarcinoma
R Sulsenti, B Frossi, L Bongiovanni, V Cancila, P Ostano, I Fischetti, ...Frontiers in immunology 12, 622001, 2021202
7
2021
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency
G Milardi, B Di Lorenzo, J Gerosa, F Barzaghi, G Di Matteo, M Omrani, ...European Journal of Immunology 2 (7), 1171-1189, 2022202
5
2022
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine
R Valsecchi, N Coltella, D Magliulo, L Bongiovanni, L Scarfò, P Ghia, ...Open Biology 10 (5), 190262, 2020202
4
2020
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency
F Barzaghi, MP Cicalese, M Zoccolillo, I Brigida, M Barcella, I Merelli, ...Frontiers in Immunology 3, 9002, 2022202
1
2022